Deloitte

Activities: Media Finance

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Media

R&D returns fall to lowest level in 9 years, says Deloitte and GlobalData

Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have fallen to 1.9%, according to a study by Deloitte’s Centre for Health Solutions leveraging revenue forecasts and industry benchmarks generated by GlobalData
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Solving the data conundrum in drug discovery

Dealing with more data does not have to mean reduced productivity. Dr Thibault Geoui, Director, Chemistry and Biomedical Products, Elsevier R&D Solutions, looks at data developments
You need to be a subscriber to read this article.
Click here to find out more.
Media

Flying the flag for quality

CPhI Pharma Insights recently published its report on the US market – produced in collaboration with research partner GBR. It reveals that while the US leads the world in many respects, there are some areas, such as biologics, where it currently lags behind

Pharma a key sector in driving India’s next wave of competitiveness

The Indian pharmaceutical industry is projected to surpass other leading emerging economies in the 21st century as a global centre for end-to-end drug discovery and innovation
Finance

European and US investors will turn to India for acquisitions, report says

Mergers and acquisitions in the pharma sector more buoyant than other industries
Subscribe now